Scottish gold producer Scotgold Resources has been challenged with an imminent leadership change after its CEO, Phil Day, announced his intention to resign.
Cross-border advisory firm, Quantuma, has appointed seasoned restructuring advisory professional Alistair Dickson as a managing director in its Glasgow office.
St Andrews-based biotech firm Pneumagen has secured £8 million in financing from existing and new investors to support the continued Phase 2 development of Neumifil, a broad-spectrum antiviral, intranasal drug for the prophylaxis and treatment of viral respiratory tract infections (RTIs).
Scottish accountancy firm, Johnston Carmichael, has expanded its senior management ranks with three new director promotions as part of its strategic leadership growth plan.
Equity Gap, the Edinburgh-based angel investment syndicate has today announced changes to its top team that will see the syndicate continue to expand its portfolio across Scotland and the UK.
Scotland’s economy demonstrated robust growth in the first quarter of 2023, outpacing the UK average, according to recent data released by the chief statistician.
German science and technology giant, Merck, has announced plans to invest €35 million (£30m) in the expansion of its biosafety testing capabilities in Glasgow and Stirling.
Scotland’s first internet of things (IoT) accelerator, the Smart Things Accelerator Centre (STAC), has heralded the amount of female-led ventures in its third cohort of companies.
In a significant strategic overhaul, accountancy and advisory firm CT (formerly Chiene + Tait), has appointed a new executive committee and strategic leadership team, along with the upcoming launch of a new seven-figure digital transformation division.
Inverlochy Castle Management International (ICMI) has extended its management agreement with Crossbasket Castle, helping support the five-star hotel as it undergoes an ambitious £15 million expansion.
Edinburgh-based Lentitek Ltd, a developer of pioneering manufacturing technologies enabling economic delivery of advanced cell and gene therapies, announced today that it has secured £250,000 ($300,000 USD) in seed investment. This investment will be deployed to further advance its technology and commence initial commercial trials.